Current and future pharmacological therapies for NAFLD/NASH.

Item

http://www.wikidata.org/entity/Q47778507

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current and future pharmacological therapies for NAFLD/NASH.

@en

Current and future pharmacological therapies for NAFLD/NASH.

@nl

type

Item

label

Current and future pharmacological therapies for NAFLD/NASH.

@en

Current and future pharmacological therapies for NAFLD/NASH.

@nl

prefLabel

Current and future pharmacological therapies for NAFLD/NASH.

@en

Current and future pharmacological therapies for NAFLD/NASH.

@nl

P1476

Current and future pharmacological therapies for NAFLD/NASH.

@en

P2093

Masashi Yoneda

http://www.w3.org/2001/XMLSchema#string

Yoshio Sumida

http://www.w3.org/2001/XMLSchema#string

P2860

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease

Decoding cell death signals in liver inflammation

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants

Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

P304

362-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00535-017-1415-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29247356

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

5847174

http://www.w3.org/2001/XMLSchema#string